- Data from the National Prostate Cancer Audit shows significantly fewer men with advanced prostate cancer are dying within three years of diagnosis compared to a decade ago.
- Patient Kevin Mortimer has seen his advanced prostate cancer become undetectable three years after a terminal diagnosis, thanks to innovative triplet therapy.
- Another patient, Kevin Webber, has survived for 12 years despite being given two years to live in 2014, raising over £1 million for Prostate Cancer UK.
- Recent improvements in survival rates are attributed to investment in cutting-edge science, research, and personalised treatment plans.
- Patients have called for continued investment in prostate cancer research to ensure more men can access life-extending therapies.
IN FULL
